Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality.

ABSTRACT: Introduction: Oncological diseases are one of the leading causes of mortality worldwide, with the high cost of therapies representing a critical barrier for health systems. Generic drugs have emerged as an alternative to reduce costs and improve access; however, their quality, safety, and efficacy remain a subject of regulatory and clinical debate. This issue is particularly sensitive in oncology, where generics often involve cytotoxic agents, narrow therapeutic indices, and complex formulations, all of which amplify the risks of therapeutic interchangeability. Materials and Methods: A multidisciplinary team composed of 19 experts in oncology, hepatology, gastroenterology, toxicology, endocrinology, and pharmacology was convened based on established academic contributions, cl

SUBMITTER: Gomez Abreo D 

PROVIDER: S-EPMC12610037 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature